St. Jude Children's Research Hospital, Inc. v. Novartis Pharmaceuticals Corporation
2:13-cv-02802
Overview
Parties
Defendant
Novartis Pharmaceuticals Corporation Operating Company
Represented By
0 Attorneys ListedPlaintiff
St. Jude Children's Research Hospital, Inc. Operating Company
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, W.D. Tennessee (tnwd)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360Β° Radar 12 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| πΊπΈ United States | Asserted | US Continuation / Sibling | View Official Patent → |
| π PCT International (WIPO) | PCT World Application | View Official Patent → | |
| π―π΅ Japan | Japan Counterpart | View Official Patent → | |
| π¨π¦ Canada | Canada Counterpart | View Official Patent → | |
| π¨π¦ Canada | Canada Counterpart | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| πͺπΊ European Patent Office (UPC States) | European Counterpart (EP) | View Official Patent → | |
| π©πͺ Germany | Germany Counterpart | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → | |
| πΊπΈ United States | US Continuation / Sibling | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5529925
Nucleic acid sequences and fusion proteins present in human t(2;5) lymphoma
|
Filed: 1993-12-03
Issued: 1996-06-25
|
Expired (Term Ended)
Expires: 2013-12-03
|
|
|
US5770421
Human ALK protein tyrosine kinase
|
Filed: 1995-10-12
Issued: 1998-06-23
|
Expired (Term Ended)
Expires: 2015-10-12
|
|
|
US6696548
Antibodies for recognition of alk protein tyrosine/kinase receptor
|
Filed: 2001-04-09
Issued: 2004-02-24
|
Expired (Term Ended)
Expires: 2014-04-10
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred β Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.
Standard Statutory Term β No obviousness-type double patenting noted.
Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).
Procedural Motions & Interlocutory Orders
Total Motions
4
Dispositive
0
Granted
4
Denied
0
Pending / Review
0
Motions by Category
Key Dispositive Motions & Rulings